Factors Associated With More Severe AD in Children
Factors associated with severe atopic dermatitis in later childhood and self-reported triggers are reported.
Dermatitis
Cutaneous, Histopathologic Features of COVID-19 in Children Identified
Cutaneous and histopathologic manifestations of COVID-19 infection in a pediatric population are described.
Patients With Hand Eczema Report High Levels of Stress
The clinic-etiological factors of patients with hand eczema were assessed.
Upadacitinib Bests Dupilumab in Atopic Dermatitis Trial
The randomized, double-blind, double-dummy, active-controlled Heads Up study included 692 patients aged 18 to 75 years with moderate to severe atopic dermatitis who are candidates for systemic therapy.
Atopic Dermatitis Linked to Increased Risk for Autoimmune Disease
The association of atopic dermatitis and autoimmune disease was investigated.
Weak Evidence of Causal Relationship of Vitamin D and Atopic Dermatitis
The causal effect of genetically predicted vitamin D levels on atopic dermatitis risk was investigated.
Increased Conjunctivitis Risk Observed in Patients Initiated Dupilumab for Atopic Dermatitis
The 6-month risk for conjunctivitis in patients with atopic dermatitis treated with dupilumab was evaluated.
Atopic Dermatitis Does Not Appear to Affect COVID-19 Severity
Investigators evaluated the relationship between atopic dermatitis and frequency of severity markers in patients hospitalized with COVID-19.
Abrocitinib Associated With Less Flare in Atopic Dermatitis Trial
The JADE REGIMEN trial was a responder-enriched, placebo-controlled withdrawal study that included a 12-week open-label run-in period.
EASI 50, SCORAD 35, and O-SCORAD 35 May Be Most Meaningful MICs for Atopic Dermatitis
The minimal important changes of percentage and absolute improvement of EASI and SCORAD scores in adults and children with AD was determined.
-
Loading...
-
Loading...
Next post in Dermatitis
